Ignite Creation Date:
2025-12-25 @ 2:09 AM
Ignite Modification Date:
2026-07-01 @ 3:03 AM
Study NCT ID:
NCT03516760
Status:
TERMINATED
Last Update Posted:
2022-09-29
First Post:
2018-04-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dose-escalating Phase I Trial With GEM333 in Patients With Acute Myeloid Leukemia
Sponsor:
AvenCell Europe GmbH
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
GEM333-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |